Identification of first in class small molecule gfral blockers for the prevention and reversal of cancer anorexia-cachexia
Ended Project Grant Awarded Last action
- Award ID
- R43CA239961
- Recipient
-
Byomass Inc. UEI N57BMT7GFJG6
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $354,845
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Place of performance
- Massachusetts, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $55,000 | |
| Original award | $299,845 |
Quick answers
Who received award R43CA239961?
R43CA239961 was awarded to Byomass Inc. by National Cancer Institute (National Institutes of Health) on September 11, 2019.
How much is award R43CA239961 worth?
$354,845 has been obligated on R43CA239961.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award